Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or High-Risk Myelodysplastic Syndrome: Randomized Phase II Study
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 105 patients (estimated)
- Sponsors
- University of Virginia
- Tags
- Randomization
- Trial Type
- Supportive
- Last Update
- 4 weeks ago
- SparkCures ID
- 1549
- NCT Identifier
- NCT04482894
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.